The new dual gastric inhibitory peptide/glucagon‐like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?-Reference-Cited by-同舟云学术

The new dual gastric inhibitory peptide/glucagon‐like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?

Published:2021-10-15 Issue:8 Volume:37 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Papachristou Stella¹,Popovic Djordje S.²³^ORCID,Papanas Nikolaos¹^ORCID

Affiliation:

1. Second Department of Internal Medicine Diabetes Centre Democritus University of Thrace University Hospital of Alexandroupolis Alexandroupolis Greece

2. Clinic for Endocrinology, Diabetes and Metabolic Disorders Clinical Center of Vojvodina Novi Sad Serbia

3. Medical Faculty University of Novi Sad Novi Sad Serbia

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3503

Reference16 articles.

1. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021

2. Glucagon-Like Peptide-1 Infusion Must Be Maintained for 24 h/day to Obtain Acceptable Glycemia in Type 2 Diabetic Patients Who Are Poorly Controlled on Sulphonylurea Treatment

3. Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real‐world data study

4. Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

5. Single-Molecule Combinatorial Therapeutics for Treating Obesity and Diabetes

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis;Cureus;2023-09-27

2. Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial;Nature Medicine;2023-05-25

3. Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A bayesian network meta-analysis;Frontiers in Pharmacology;2022-10-14

4. Novel Drugs for Diabetes Therapy;From Obesity to Diabetes;2022